Researchers find a signaling pathway that limits mammary basal cells’ ability to fuel the growth of multiple aggressive cell populations within a breast tumor, uncovering opportunities for novel therapeutic approaches to breast cancer.
NCCC treats the first patients with new CAR T-cell therapy.
Kim Levitch becomes the first patient at Norris Cotton Cancer Center to undergo the newest cancer immunotherapy, CAR T-cell therapy.
Dartmouth-Hitchcock Norris Cotton Cancer Center leads a new multi-center Phase I in-human clinical trial of anti-VISTA, a therapeutic antibody designed to target a molecule that keeps the immune system quiet against cancer.
This Press Ganey award recognizes institutions who have maintained consistently high levels of excellence in patient experience over a three-year period.
A newly awarded $820,000 grant from The National Cancer Institute (NCI) will allow a team of investigators to increase clinical trial awareness and participation for rural patients.
Sarcomas develop in bones or connective tissues. Here are 10 things you may not know about this uncommon group of cancers.
Four years after completing treatment for colon cancer, Dia Draper reflects on life in survivorship and the complex emotions and changes in life perspective that come along with surviving a serious illness.
To avoid activities that could cause the spread of the COVID-19 virus, we have made the decision to cancel, postpone or transition to virtual events all in-person fundraising, engagement or stewardship events through December 31, 2020.
In this Q&A series, Jason Faris, MD details some exciting and innovating early-phase trials underway at the cancer center.